Biologics & Biosimilars in Rheumatology
April 27, 2022
Biologic drugs, including biosimilars, are increasing the number of effective treatments for rheumatic diseases. Biologics are derived from living organisms, such as microorganisms or human tissue. And the number of these drugs available to patients has increased exponentially in recent decades. Today, biologics are used to treat a range of conditions, including chronic illnesses such as cancers, multiple sclerosis and rheumatic diseases.
Categorized in: Policy Briefs, Policy Papers